Authors:
DUAN JM
PARIS W
KIBLER P
BOUSQUET C
LIUZZI M
CORDINGLEY MG
Citation: Jm. Duan et al., DOSE AND DURATION-DEPENDENCE OF GANCICLOVIR TREATMENT AGAINST MURINE CYTOMEGALOVIRUS-INFECTION IN SEVERE COMBINED IMMUNODEFICIENT MICE, Antiviral research, 39(3), 1998, pp. 189-197
Authors:
DUAN JM
LIUZZI M
PARIS W
LAMBERT M
LAWETZ C
MOSS N
JARAMILLO J
GAUTHIER J
DEZIEL R
CORDINGLEY MG
Citation: Jm. Duan et al., ANTIVIRAL ACTIVITY OF A SELECTIVE RIBONUCLEOTIDE REDUCTASE INHIBITOR AGAINST ACYCLOVIR-RESISTANT HERPES-SIMPLEX VIRUS TYPE-1 IN-VIVO, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1629-1635
Authors:
TONG L
QIAN CE
DAVIDSON W
MASSARIOL MJ
BONNEAU PR
CORDINGLEY MG
LAGACE L
Citation: L. Tong et al., EXPERIENCES FROM THE STRUCTURE DETERMINATION OF HUMAN CYTOMEGALOVIRUSPROTEASE, Acta crystallographica. Section D, Biological crystallography, 53, 1997, pp. 682-690
Authors:
DO F
MASSARIOL MJ
LAGACE L
BAILEY M
HALMOS T
DEZIEL R
CORDINGLEY MG
Citation: F. Do et al., INHIBITION OF HUMAN CYTOMEGALOVIRUS PROTEASE PRECURSOR AND ASSEMBLY PROTEIN PROCESSING BY PEPTIDOMIMETIC INHIBITORS OF HCMV PROTEASE, The FASEB journal, 11(9), 1997, pp. 2154-2154
Authors:
MCKERCHER G
BONNEAU PR
LAGACE L
THIBEAULT D
MASSARIOL MJ
KROGSRUD R
LAWETZ C
MCDONALD PC
CORDINGLEY MG
Citation: G. Mckercher et al., IMPROVED PURIFICATION PROTOCOL OF THE HSV-1 PROTEASE CATALYTIC DOMAIN, USING IMMUNOAFFINITY, Biochemistry and cell biology, 75(6), 1997, pp. 795-801
Authors:
PELLETIER A
DO F
BRISEBOIS JJ
LAGACE L
CORDINGLEY MG
Citation: A. Pelletier et al., SELF-ASSOCIATION OF HERPES-SIMPLEX VIRUS TYPE-1 ICP35 IS VIA COILED-COIL INTERACTIONS AND PROMOTES STABLE INTERACTION WITH THE MAJOR CAPSIDPROTEIN, Journal of virology, 71(7), 1997, pp. 5197-5208
Authors:
TONG L
QIAN CG
MASSARIOL MJ
BONNEAU PR
CORDINGLEY MG
LAGACE L
Citation: L. Tong et al., A NEW SERINE-PROTEASE FOLD REVEALED BY THE CRYSTAL-STRUCTURE OF HUMANCYTOMEGALOVIRUS PROTEASE, Nature, 383(6597), 1996, pp. 272-275
Authors:
BONNEAU AM
KIBLER P
WHITE P
BOUSQUET C
DANSEREAU N
CORDINGLEY MG
Citation: Am. Bonneau et al., RESISTANCE OF HERPES-SIMPLEX VIRUS TYPE-1 TO PEPTIDOMIMETIC RIBONUCLEOTIDE REDUCTASE INHIBITORS - SELECTION AND CHARACTERIZATION OF MUTANT ISOLATES, Journal of virology, 70(2), 1996, pp. 787-793
Citation: Mg. Cordingley et al., RELEASE ANALYSIS AND ITS USE IN THE OPTIMIZATION OF THE COMMINUTION AND GRAVITY CIRCUITS AT THE WHEAL JANE TIN CONCENTRATOR, Minerals engineering, 7(12), 1994, pp. 1517-1526
Authors:
ARCHER TK
LEE HL
CORDINGLEY MG
MYMRYK JS
FRAGOSO G
BERARD DS
HAGER GL
Citation: Tk. Archer et al., DIFFERENTIAL STEROID-HORMONE INDUCTION OF TRANSCRIPTION FROM THE MOUSE MAMMARY-TUMOR VIRUS PROMOTER, Molecular endocrinology, 8(5), 1994, pp. 568-576
Citation: M. Gao et al., THE C-TERMINAL 3RD OF UL42, A HSV-1 DNA-REPLICATION PROTEIN, IS DISPENSABLE FOR VIRAL GROWTH, Virology, 194(2), 1993, pp. 647-653
Authors:
WEINHEIMER SP
MCCANN PJ
OBOYLE DR
STEVENS JT
BOYD BA
DRIER DA
YAMANAKA GA
DIIANNI CL
DECKMAN IC
CORDINGLEY MG
Citation: Sp. Weinheimer et al., AUTOPROTEOLYSIS OF HERPES-SIMPLEX VIRUS TYPE-1 PROTEASE RELEASES AN ACTIVE CATALYTIC DOMAIN FOUND IN INTERMEDIATE CAPSID PARTICLES, Journal of virology, 67(10), 1993, pp. 5813-5822
Authors:
HAMATAKE RK
BIFANO M
TENNEY DJ
HURLBURT WW
CORDINGLEY MG
Citation: Rk. Hamatake et al., THE HERPES-SIMPLEX VIRUS TYPE-1 DNA-POLYMERASE ACCESSORY PROTEIN, UL42, CONTAINS A FUNCTIONAL PROTEASE-RESISTANT DOMAIN, Journal of General Virology, 74, 1993, pp. 2181-2189
Authors:
DIIANNI CL
MAPELLI C
DRIER DA
TSAO J
NATARAJAN S
RIEXINGER D
FESTIN SM
BOLGAR M
YAMANAKA G
WEINHEIMER SP
MEYERS CA
COLONNO RJ
CORDINGLEY MG
Citation: Cl. Diianni et al., IN-VITRO ACTIVITY OF THE HERPES-SIMPLEX VIRUS TYPE-1 PROTEASE WITH PEPTIDE-SUBSTRATES, The Journal of biological chemistry, 268(34), 1993, pp. 25449-25454